Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

May 31, 2011

Conditions
Lymphoma
Interventions
DRUG

doxorubicin hydrochloride

given IV

DRUG

gemcitabine hydrochloride

given IV

DRUG

vinblastine

given IV

PROCEDURE

fludeoxyglucose F 18 positron-emission tomography (PET) scan

PROCEDURE

CT scan

Trial Locations (47)

10021

Memorial Sloan-Kettering Cancer Center, New York

New York Weill Cornell Cancer Center at Cornell University, New York

12801

Charles R. Wood Cancer Center at Glens Falls Hospital, Glens Falls

13057

CCOP - Hematology-Oncology Associates of Central New York, Syracuse

13210

SUNY Upstate Medical University Hospital, Syracuse

13215

Community General Hospital, Syracuse

19713

CCOP - Christiana Care Health Services, Newark

19958

Beebe Medical Center, Lewes

20007

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

21921

Union Hospital Cancer Center at Union Hospital, Elkton MD

27534

Wayne Memorial Hospital, Incorporated, Goldsboro

Wayne Radiation Oncology, Goldsboro

28501

Lenoir Memorial Cancer Center, Kinston

29601

Bon Secours St. Francis Health System, Greenville

29615

CCOP - Greenville, Greenville

46350

Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte

46515

Elkhart General Hospital, Elkhart

46601

CCOP - Northern Indiana CR Consortium, South Bend

Memorial Hospital of South Bend, South Bend

46617

Saint Joseph Regional Medical Center, South Bend

46904

Howard Community Hospital at Howard Regional Health System, Kokomo

49085

Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph, Saint Joseph

52402

Iowa Blood and Cancer Care, Cedar Rapids

St. Luke's Hospital, Cedar Rapids

52403

Mercy Regional Cancer Center at Mercy Medical Center, Cedar Rapids

55455

University of Minnesota Medical Center - Fairview, Minneapolis

63110

Siteman Cancer Center at Barnes-Jewish Hospital, St Louis

65201

Missouri Cancer Associates, Columbia

68803

Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center, Grand Island

94115

UCSF Comprehensive Cancer Center, San Francisco

20307-5001

Walter Reed Army Medical Center, Washington D.C.

60637-1470

University of Chicago Cancer Research Center, Chicago

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber/Brigham and Women's Cancer Center, Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

69101-6598

Great Plains Regional Medical Center, North Platte

68198-6805

UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

28233-3549

Presbyterian Cancer Center at Presbyterian Hospital, Charlotte

27893-3428

Wilson Medical Center, Wilson

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus

05602

Mountainview Medical, Berlin Corners

05401

Fletcher Allen Health Care - University Health Center Campus, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00086801 - Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter